Amsurg Corp Reaffirms FY 2013 Revenue Guidance; Raises FY 2013 EPS Guidance; Issues Q3 2013 EPS Guidance In Line With Analysts' Estimates


Tuesday, 23 Jul 2013 04:01pm EDT 

Amsurg Corp announced that for fiscal 2013, it expects revenue to be in the range of $1.06 billion to $1.09 billion, net earnings from continuing operations per diluted share (EPS) attributable to common shareholders in a range of $2.17 to $2.20, excluding the impact of the deconsolidation gain, compared with the previous range of $2.13 to $2.18, excluding the impact of the deconsolidation gain. For third quarter of 2013, it expects net earnings from continuing operations per diluted share attributable to common shareholders in a range of $0.51 to $0.53. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $1.06 billion and EPS of $2.16 for fiscal 2013; EPS of $0.53 for third quarter of 2013. 

Company Quote

53.35
1.175 +2.25%
19 Dec 2014